AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02465606 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical Corticosteroid Creams (Triamcinolone acetonide 0.1% and Hydrocortisone 2.5%)
Description: Triamcinolone acetonide 0.1% cream will be supplied as single 454-g jars to be used on the body. Hydrocortisone 2.5% cream will be supplied as single 28-g tubes to be used on the face and intertriginous areas as indicated.
Study NCT04269811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flu-Bu-Mel
Description: 5-day fludarabine + 2-day busulfan (3.2mg/kg) + 2-day melphalan (50-70mg/m2)
Study NCT01441258 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy Skills (DBT-S) Groups
Description: The intervention will be delivered within an 18-week, once-weekly, one-and-half-hour skill group (8 participants per group) comprised of the same four modules administered in standard DBT skills training groups: (1) mindfulness, (2) interpersonal effectiveness, (3) emotion regulation, and (4) distress tolerance. There will be four sessions for each module totaling 16 sessions. There will be two booster sessions reviewing mindfulness and the concept of dialectics in-between each of the modules (i.e., between modules 2 and 3 and 3 and 4).
Study NCT01441258 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Wait List-Treatment as Usual
Description: Participants will be seen by their standard treaters for 18 weeks as usual.
Study NCT01441258 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No intervention-treatment as usual
Description: Participants will receive the intervention after 18 weeks in the treatment as usual group.
Study NCT01497678 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Extracellular Matrix
Description: Extracellular Matrix
Study NCT02076802 — intervention group
Intervention type: BEHAVIORAL
Intervention: physical exercises
Study NCT06415071 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Exposures of interest would be clearly defined according to a specific research question and identified from the database
Study NCT01786551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eplerenone
Description: 50 mg daily for 14 days
Study NCT00692757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypochlorous acid
Description: Hypochlorous acid for preoperative scrubbing to prevent surgical site infection in spray
Study NCT00692757 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iodopovidone
Description: Iodopovidone
Study NCT02674178 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Invitro fertilization
Description: All participants underwent long protocol. Daily SC injection of Triptorelin 0.1 mg started at day 21 of the cycle prior to stimulation cycle and continued till the day of hCG injection. Gn stimulation started in a starting dose of 150-300 IU/day depending on patients age and previous gonadotropin response. then the dose was adjusted according to ovarian response monitored by serum E2 and ultrasound evaluation. All patients were followed up by Transvaginal ultrasound scan daily or on alternate days~Triggering by HCG 10000 IU IM when at least 2 follicles reached a mean diameter of 18 mm \[18\]~Ovum pick-up (OPU) was done 34-36 hours after hCG injection Transfer of cleaving embryos was done on day 3 after oocyte retrieval
Study NCT02575807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epacadostat
Description: PO BID
Study NCT01090726 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Storz videolaryngoscope
Description: Storz videolaryngoscope being used for the actual intubation
Study NCT01090726 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Airtraq
Description: Airtraq being used for the actual intubation
Study NCT01705288 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparotomy
Description: Exploratory surgery for gynecologic diagnosis.Involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), early eating after surgery, early walking, and certain goals for discharge from the hospital
Study NCT01705288 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparotomy
Description: Exploratory surgery for gynecologic diagnosis.Involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), early eating after surgery, early walking, and certain goals for discharge from the hospital
Study NCT00895115 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham intervention
Description: No supplementation
Study NCT03392220 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unilateral Neck Dissection
Description: patient undergo unilateral (affected side) neck dissection, along with the excision of the laryngeal primary tumor
Study NCT01705288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intravenous narcotics
Description: given for pain management after surgery per physician orders
Study NCT01705288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard anesthesia
Description: inhalant or intravenous during surgery
Study NCT01705288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: regional anesthesia
Description: given by spinal or epidural infusion
Study NCT01705288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs
Description: given for pain management after surgery
Study NCT01743261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multidisciplinary intervention
Description: Multidisciplinary intervention Instruments of governance are the diagnostic-therapeutic rehabilitation pathways (DTRP), the Quality system and product standards; Medical care process with result-oriented autonomy Technology support of vital signs.
Study NCT01743261 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: usual care
Description: specific pathology. access is determined by clinical stability. the instruments of governance are guidelines and consensus and the rehabilitation programme is focused on functional and cognitive areas.~the medical care process is governed by hierarchy. The technology in this model is limited to a specific specialty
Study NCT02575807 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: via IV infusion
Study NCT00956410 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAD106
Study NCT03407326 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alternative RUTF
Description: The alternative RUTF contains oat, peanuts, sugar, milk powder, vegetable oil as well as premix containing concentrated minerals and vitamins and emulsifier.
Study NCT03392220 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral Neck Dissection
Description: patient undergo bilateral neck dissection, along with the excision of the laryngeal primary tumor
Study NCT01926834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erigeron Injection
Description: Erigeron Injection, 30ml, iv, qd, for 7days
Study NCT01753570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RBV(48 weeks)
Description: RBV: 600 - 1000mg/day based on body weight for 48 weeks
Study NCT03407326 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard RUTF
Description: Standard RUTF contains peanut paste, sugar, non-fat dried milk (NFDM), vegetable oil, a premix containing concentrated minerals and vitamins, and emulsifier.
Study NCT00403273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Description: 100 units of Botulinum toxin A in 5 cc of normal saline in the Painful TKA at screening visit
Study NCT00403273 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Single Intra-articular Injection of 5 cc of normal saline in the Painful TKA at screening visit
Study NCT00437294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enzastaurin
Description: 1125 milligrams (mg) loading dose then 500 mg, oral, daily, 21-day cycles until progressive disease
Study NCT00437294 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: oral, daily, 21-day cycles until progressive disease
Study NCT00437294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Description: 1250 mg/m\^2, BID, days 1-14 of each 21-day cycle until progressive disease
Study NCT00437294 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: capecitabine
Description: 1250 mg/m\^2, BID, days 1-14 of each 21-day cycle until progressive disease
Study NCT01541644 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Participants will receive acupuncture treatment twice weekly for 2 weeks, then once per week for 4 weeks, and then biweekly for 4 weeks.
Study NCT02491086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT) sampling
Description: 1-week free NRT
Study NCT02491086 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking cessation counseling
Description: Smoking cessation counseling
Study NCT04124172 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Real rTMS (Magstim)
Description: See arm description
Study NCT04124172 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: See arm description
Study NCT02266056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block using rocuronium and reversal with suggamadex
Description: Deep neuromuscular block and moderate neuromuscular block with Esmerone and reversal with bridion
Study NCT02266056 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moderate neuromuscular block using rocuronium and reversal with suggamadex
Description: Moderate neuromuscular block and moderate neuromuscular block with Esmerone and reversal with bridion
Study NCT02110992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel 15mg/m2 IV, given days 1, 8, and 15 during SBRT
Study NCT02110992 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiation
Description: SBRT will be given over 5 fractions separated by > 48 hours. Dose will be determined based upon dose escalation schedule and will range from 25-40 Gy.
Study NCT02145039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine 30 mg/m2 IV over 30-60 minutes on days -6 through -2 before transplant.
Study NCT02145039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide 14.5 mg/kg IV over 1-2 hours on days -6 and -5 before transplant and Cyclophosphamide 50 mg/kg IV on days 3 and 4 post-transplant.
Study NCT02491086 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling
Description: Smoking cessation counseling
Study NCT01905891 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Superficial shave biopsy
Description: Sample will be obtained from random dorsal forearm skin sites without evidence of keratotic lesions. The site will be selected by the investigator. Skin will first be wiped with an alcohol pad and 1% lidocaine will be superficially infiltrated per standard skin surgical procedures. 30% trichloroacetic acid (TCA, standard chemical peel) will then be applied for five minutes. TCA will be neutralized using bicarbonate. Using a cytology brush (a small brush which is used to collect cells during the course of a biopsy) cells will be collected by gentle scraping surface of the skin. Then, a superficial shave biopsy specimen, obtained by using a dermablade (a flexible, one piece blade specifically designed for shave biopsy and excision of skin lesions) will be obtained.
Study NCT04366258 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Photobiomodulator
Description: Delivers laser-generated Near-Infrared Radiation (NIR) to forehead at 3 doses of irradiance - High (770 mW/cm2), Middle (300 mW/cm2), and Low (50 mW/cm2).
Study NCT04366258 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham
Description: Transcranial Photobiomodulator delivers sham irradiance dose of 0 mW/cm2.
Study NCT02145039 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total Body Irradiation
Description: TBI 200cGy on day -1 before transplant.
Study NCT01828164 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: The Aevo System™ is an ultrasound emitting dental device.
Study NCT01828164 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: Ultrasound not activated in the comparator side of the device.20 minutes per day of ultrasound treatment on the active side of the device. The device consists of a mouth guard type device with transducers embedded in the mouth guard. In the split mouth design, the treatment arm consist of the side of the mouth with the transducers activated while the comparator arm has the transducers deactivated.
Study NCT02145039 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Haploidentical stem cell transplant
Description: Non-T-cell depleted bone marrow infusion
Study NCT01926834 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: normal saline, 500ml,i.v.,qd, for 7 days
Study NCT04415814 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unilateral Pedicle Screw Fixation
Description: Pedicle screws are installed unilaterally on the one side of the vertebrae and fixed with rod
Study NCT04415814 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral Pedicle Screw Fixation
Description: Pedicle screws are installed bilaterally on the both sides of the vertebrae and fixed with rods
Study NCT02064452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Triple P Online System
Description: The Triple P Online System (TPOS) is an online parenting support program designed to assist parents in developing effective parenting practices for handling their children's problem behaviors. Content focuses on positive attention and praise, teaching strategies, effective discipline, antecedent strategies to avoid problems in high-risk situations, and applying these principles to specific situations. TPOS integrates 3 different levels of program intensity to meet different levels of family need, based on severity of children's behavior problems.
Study NCT02064452 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Enhanced Usual Community Care-Waitlist
Study NCT00495950 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaires relating to symptoms experienced during and following standard cancer treatment.
Study NCT02401217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 1- Arm 1 Infant Formula
Description: Powder infant formula
Study NCT02401217 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Phase 2- Arm 2 Infant Formula
Description: Powder infant formula
Study NCT02401217 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phase 2- Arm 3 Infant Formula
Description: Powder infant formula
Study NCT00925795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: consumption 1. EVOO; 2. ROO
Description: EVOO in doses of 50 mL/daily for 20 days; 14 days of wash-out period without olives and olive oil; followed by ROO in doses of 50 mL/daily for 20 days
Study NCT00925795 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: consumption 1. ROO; 2. EVOO
Description: ROO in doses of 50 mL/daily for 20 days; 14 days of wash-out period without olives and olive oil; followed by EVOO in doses of 50 mL/daily for 20 days
Study NCT03940898 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: There are two types of stimulation equipment, one is the transcranial magnetic stimulator model Magpro X100 produced by Danish Medtronic, and the other is the CCY-I TMS stimulator produced by Wuhan Eride, model B9076. The stimulating magnetic head uses an 8 shaped coil, and the stimulation site is the cerebellar vermis (ie, 1 cm below the occipital bulge), and the stimulation intensity is 100% of the motor threshold.The base frequency of the iTBS mode is 5 Hz, and one short burst stimulus occurs every 200 milliseconds. In each short array, three single pulses with a frequency of 50 Hz are buried, and each 10 short burst stimulation intervals are 8 seconds, for a total of 200 short burst stimulations. The total number of stimulation pulses is 600 per day.It takes 3 minutes and 20 seconds to complete one intervention. All participants were intervened once a day for 5 times a week for 2 weeks for a total of 10 times.
Study NCT03940898 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: There are two types of stimulation equipment, one is the transcranial magnetic stimulator model Magpro X100 produced by Danish Medtronic, and the other is the CCY-I TMS stimulator produced by Wuhan Eride, model B9076. The stimulating magnetic head uses an 8 shaped coil, and the stimulation site is the cerebellar vermis (ie, 1 cm below the occipital bulge), and the stimulation intensity is 100% of the motor threshold.The base frequency of the iTBS mode is 5 Hz, and one short burst stimulus occurs every 200 milliseconds. In each short array, three single pulses with a frequency of 50 Hz are buried, and each 10 short burst stimulation intervals are 8 seconds, for a total of 200 short burst stimulations. The total number of stimulation pulses is 600 per day.It takes 3 minutes and 20 seconds to complete one intervention. All participants were intervened once a day for 5 times a week for 2 weeks for a total of 10 times.
Study NCT01564680 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: normal saline
Study NCT01564680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: IV paracetamol infusion
Study NCT01564680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lornoxicam
Description: 16 mg at skin closure and 8 mg 12 hours postoperative
Study NCT03079648 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Angelica gigas N. extract
Description: capsules (2cap/d, 1,000mg/d) for 12 weeks.
Study NCT03079648 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for 12 weeks
Study NCT03373825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Take home rapid drug test
Description: The Rapid Response fentanyl test strips will be offered as take-home rapid drug tests to all participants to assess the willingness to use take-home rapid drug tests and the feasibility of using such an intervention at home. Arm 1 will be offered one method of using the take-home rapid drug test (urine testing). Arm 2 will be offered a second method of using the take-home rapid drug test (testing drug residue).
Study NCT02861404 — intervention group
Intervention type: GENETIC
Intervention: skin flakes collection
Description: viral status assessment of skin flakes
Study NCT01753570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IFN beta(48 weeks)
Description: IFN beta: 600 MIU/day,6 days/week for initial 4 weeks following to 3 days/week for 48 weeks
Study NCT01226160 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Postoperative face-down posturing
Description: Postoperative face-down posturing for 10 days after surgery.
Study NCT01056458 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: auricular acupressure
Description: use the tape of ear adhesive beads on shenmen and subcortical area of both ears after three meals and before bed for three minutes each area with alternating ears, twice a week to replace paste.
Study NCT01056458 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham acupressure
Description: use only tape without ear adhesive beads under the same ways
Study NCT00186875 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Etoposide, cytarabine, vincristine, dexamethasone
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: methotrexate, teniposide, PEG-asparaginase
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: L-asparaginase, erwinia asparaginase
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: chemotherapy, intrathecal chemotherapy, steroid therapy
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Hematopoietic Stem Cell Transplant
Description: See Detailed Description section for details of treatment interventions.
Study NCT00186875 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Natural Killer (NK) Cell Transplant
Description: See Detailed Description section for details of treatment interventions.
Study NCT00750373 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Valve surgery with removal of vegetations
Description: Early valve repair or replacement with removal of vegetations within 48 hours of randomization